nodes	percent_of_prediction	percent_of_DWPC	metapath
Ibuprofen—ALB—acquired immunodeficiency syndrome	0.152	1	CbGaD
Ibuprofen—UGT1A1—Abacavir—acquired immunodeficiency syndrome	0.0456	0.0791	CbGbCtD
Ibuprofen—UGT2B7—Zidovudine—acquired immunodeficiency syndrome	0.0247	0.0428	CbGbCtD
Ibuprofen—ABCC1—Amprenavir—acquired immunodeficiency syndrome	0.0241	0.0419	CbGbCtD
Ibuprofen—SLC22A6—Stavudine—acquired immunodeficiency syndrome	0.0239	0.0414	CbGbCtD
Ibuprofen—SLC22A11—Zidovudine—acquired immunodeficiency syndrome	0.0235	0.0407	CbGbCtD
Ibuprofen—ABCC4—Zidovudine—acquired immunodeficiency syndrome	0.0218	0.0379	CbGbCtD
Ibuprofen—ABCC1—Indinavir—acquired immunodeficiency syndrome	0.0208	0.0362	CbGbCtD
Ibuprofen—SLCO1A2—Indinavir—acquired immunodeficiency syndrome	0.0186	0.0323	CbGbCtD
Ibuprofen—ABCC1—Saquinavir—acquired immunodeficiency syndrome	0.0183	0.0317	CbGbCtD
Ibuprofen—ABCC1—Ritonavir—acquired immunodeficiency syndrome	0.0183	0.0317	CbGbCtD
Ibuprofen—SLC22A6—Didanosine—acquired immunodeficiency syndrome	0.0181	0.0314	CbGbCtD
Ibuprofen—SLCO1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0181	0.0313	CbGbCtD
Ibuprofen—ABCC4—Lamivudine—acquired immunodeficiency syndrome	0.0169	0.0293	CbGbCtD
Ibuprofen—SLCO1A2—Saquinavir—acquired immunodeficiency syndrome	0.0163	0.0283	CbGbCtD
Ibuprofen—SLCO1A2—Ritonavir—acquired immunodeficiency syndrome	0.0163	0.0283	CbGbCtD
Ibuprofen—SLC22A8—Zidovudine—acquired immunodeficiency syndrome	0.0136	0.0237	CbGbCtD
Ibuprofen—ABCC1—Lamivudine—acquired immunodeficiency syndrome	0.0136	0.0235	CbGbCtD
Ibuprofen—SLC22A6—Zidovudine—acquired immunodeficiency syndrome	0.0095	0.0165	CbGbCtD
Ibuprofen—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.00861	0.0149	CbGbCtD
Ibuprofen—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.00861	0.0149	CbGbCtD
Ibuprofen—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.00849	0.0147	CbGbCtD
Ibuprofen—ALB—Saquinavir—acquired immunodeficiency syndrome	0.00844	0.0146	CbGbCtD
Ibuprofen—ALB—Zidovudine—acquired immunodeficiency syndrome	0.00809	0.014	CbGbCtD
Ibuprofen—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.00799	0.0139	CbGbCtD
Ibuprofen—SLC22A6—Lamivudine—acquired immunodeficiency syndrome	0.00735	0.0128	CbGbCtD
Ibuprofen—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.00722	0.0125	CbGbCtD
Ibuprofen—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.00722	0.0125	CbGbCtD
Ibuprofen—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.00706	0.0122	CbGbCtD
Ibuprofen—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.00664	0.0115	CbGbCtD
Ibuprofen—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.00664	0.0115	CbGbCtD
Ibuprofen—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.00652	0.0113	CbGbCtD
Ibuprofen—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.00652	0.0113	CbGbCtD
Ibuprofen—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.00644	0.0112	CbGbCtD
Ibuprofen—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.00625	0.0108	CbGbCtD
Ibuprofen—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.00623	0.0108	CbGbCtD
Ibuprofen—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.00605	0.0105	CbGbCtD
Ibuprofen—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.006	0.0104	CbGbCtD
Ibuprofen—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.006	0.0104	CbGbCtD
Ibuprofen—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.00583	0.0101	CbGbCtD
Ibuprofen—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.00547	0.00949	CbGbCtD
Ibuprofen—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.00547	0.00949	CbGbCtD
Ibuprofen—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.00525	0.0091	CbGbCtD
Ibuprofen—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.00518	0.00899	CbGbCtD
Ibuprofen—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.00503	0.00873	CbGbCtD
Ibuprofen—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.00503	0.00872	CbGbCtD
Ibuprofen—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.00488	0.00847	CbGbCtD
Ibuprofen—CFTR—semen—acquired immunodeficiency syndrome	0.00456	0.0746	CbGeAlD
Ibuprofen—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.00455	0.00789	CbGbCtD
Ibuprofen—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.00455	0.00789	CbGbCtD
Ibuprofen—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.00442	0.00766	CbGbCtD
Ibuprofen—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.00442	0.00766	CbGbCtD
Ibuprofen—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.00436	0.00757	CbGbCtD
Ibuprofen—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00423	0.00734	CbGbCtD
Ibuprofen—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00327	0.00568	CbGbCtD
Ibuprofen—L-Tyrosine—TAT—acquired immunodeficiency syndrome	0.00283	0.861	CrCbGaD
Ibuprofen—THBD—endothelium—acquired immunodeficiency syndrome	0.00262	0.0429	CbGeAlD
Ibuprofen—THBD—blood plasma—acquired immunodeficiency syndrome	0.00233	0.0381	CbGeAlD
Ibuprofen—FABP2—digestive system—acquired immunodeficiency syndrome	0.0014	0.0229	CbGeAlD
Ibuprofen—THBD—skin of body—acquired immunodeficiency syndrome	0.00112	0.0183	CbGeAlD
Ibuprofen—UGT1A1—blood plasma—acquired immunodeficiency syndrome	0.0011	0.018	CbGeAlD
Ibuprofen—THBD—lymphoid tissue—acquired immunodeficiency syndrome	0.000908	0.0148	CbGeAlD
Ibuprofen—PLAT—retina—acquired immunodeficiency syndrome	0.000899	0.0147	CbGeAlD
Ibuprofen—THBD—digestive system—acquired immunodeficiency syndrome	0.000896	0.0146	CbGeAlD
Ibuprofen—PPARG—endothelium—acquired immunodeficiency syndrome	0.000889	0.0145	CbGeAlD
Ibuprofen—UGT1A3—digestive system—acquired immunodeficiency syndrome	0.000866	0.0141	CbGeAlD
Ibuprofen—THBD—blood—acquired immunodeficiency syndrome	0.000854	0.014	CbGeAlD
Ibuprofen—THBD—spinal cord—acquired immunodeficiency syndrome	0.000823	0.0134	CbGeAlD
Ibuprofen—FABP2—lymph node—acquired immunodeficiency syndrome	0.0008	0.0131	CbGeAlD
Ibuprofen—THBD—vagina—acquired immunodeficiency syndrome	0.000792	0.0129	CbGeAlD
Ibuprofen—BCL2—skin of body—acquired immunodeficiency syndrome	0.00079	0.0129	CbGeAlD
Ibuprofen—PPARG—blood plasma—acquired immunodeficiency syndrome	0.000789	0.0129	CbGeAlD
Ibuprofen—UGT2B4—lung—acquired immunodeficiency syndrome	0.000754	0.0123	CbGeAlD
Ibuprofen—THBD—lung—acquired immunodeficiency syndrome	0.000749	0.0122	CbGeAlD
Ibuprofen—ABCC4—blood plasma—acquired immunodeficiency syndrome	0.000717	0.0117	CbGeAlD
Ibuprofen—THBD—nervous system—acquired immunodeficiency syndrome	0.000693	0.0113	CbGeAlD
Ibuprofen—THBD—central nervous system—acquired immunodeficiency syndrome	0.000667	0.0109	CbGeAlD
Ibuprofen—CFTR—digestive system—acquired immunodeficiency syndrome	0.000639	0.0104	CbGeAlD
Ibuprofen—BCL2—lymphoid tissue—acquired immunodeficiency syndrome	0.000639	0.0104	CbGeAlD
Ibuprofen—BCL2—digestive system—acquired immunodeficiency syndrome	0.000632	0.0103	CbGeAlD
Ibuprofen—UGT1A9—digestive system—acquired immunodeficiency syndrome	0.000617	0.0101	CbGeAlD
Ibuprofen—CFTR—blood—acquired immunodeficiency syndrome	0.000609	0.00995	CbGeAlD
Ibuprofen—BCL2—blood—acquired immunodeficiency syndrome	0.000602	0.00983	CbGeAlD
Ibuprofen—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.000596	0.00974	CbGeAlD
Ibuprofen—BCL2—bone marrow—acquired immunodeficiency syndrome	0.000582	0.00951	CbGeAlD
Ibuprofen—PLAT—spinal cord—acquired immunodeficiency syndrome	0.00058	0.00947	CbGeAlD
Ibuprofen—PLAT—vagina—acquired immunodeficiency syndrome	0.000558	0.00911	CbGeAlD
Ibuprofen—CXCL8—blood—acquired immunodeficiency syndrome	0.000557	0.0091	CbGeAlD
Ibuprofen—CXCL8—bone marrow—acquired immunodeficiency syndrome	0.000539	0.00881	CbGeAlD
Ibuprofen—CXCL8—spinal cord—acquired immunodeficiency syndrome	0.000537	0.00877	CbGeAlD
Ibuprofen—CFTR—lung—acquired immunodeficiency syndrome	0.000534	0.00872	CbGeAlD
Ibuprofen—THBD—brain—acquired immunodeficiency syndrome	0.00053	0.00866	CbGeAlD
Ibuprofen—PLAT—lung—acquired immunodeficiency syndrome	0.000527	0.00862	CbGeAlD
Ibuprofen—BCL2—lung—acquired immunodeficiency syndrome	0.000527	0.00862	CbGeAlD
Ibuprofen—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.00052	0.0085	CbGeAlD
Ibuprofen—CXCL8—vagina—acquired immunodeficiency syndrome	0.000516	0.00844	CbGeAlD
Ibuprofen—THBD—lymph node—acquired immunodeficiency syndrome	0.000512	0.00837	CbGeAlD
Ibuprofen—UGT2B7—digestive system—acquired immunodeficiency syndrome	0.000497	0.00812	CbGeAlD
Ibuprofen—BCL2—nervous system—acquired immunodeficiency syndrome	0.000488	0.00798	CbGeAlD
Ibuprofen—CXCL8—lung—acquired immunodeficiency syndrome	0.000488	0.00798	CbGeAlD
Ibuprofen—SLC22A11—digestive system—acquired immunodeficiency syndrome	0.000485	0.00792	CbGeAlD
Ibuprofen—PTGS1—endothelium—acquired immunodeficiency syndrome	0.000475	0.00776	CbGeAlD
Ibuprofen—BCL2—central nervous system—acquired immunodeficiency syndrome	0.00047	0.00768	CbGeAlD
Ibuprofen—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000462	0.00755	CbGeAlD
Ibuprofen—PTGS2—endothelium—acquired immunodeficiency syndrome	0.000454	0.00742	CbGeAlD
Ibuprofen—UGT1A1—digestive system—acquired immunodeficiency syndrome	0.000423	0.00691	CbGeAlD
Ibuprofen—PTGS1—blood plasma—acquired immunodeficiency syndrome	0.000422	0.00689	CbGeAlD
Ibuprofen—PTGS2—blood plasma—acquired immunodeficiency syndrome	0.000403	0.00659	CbGeAlD
Ibuprofen—UGT1A1—blood—acquired immunodeficiency syndrome	0.000403	0.00658	CbGeAlD
Ibuprofen—PPARG—skin of body—acquired immunodeficiency syndrome	0.000379	0.0062	CbGeAlD
Ibuprofen—CFTR—brain—acquired immunodeficiency syndrome	0.000378	0.00618	CbGeAlD
Ibuprofen—PLAT—brain—acquired immunodeficiency syndrome	0.000373	0.0061	CbGeAlD
Ibuprofen—BCL2—brain—acquired immunodeficiency syndrome	0.000373	0.0061	CbGeAlD
Ibuprofen—PLAT—lymph node—acquired immunodeficiency syndrome	0.000361	0.00589	CbGeAlD
Ibuprofen—BCL2—lymph node—acquired immunodeficiency syndrome	0.000361	0.00589	CbGeAlD
Ibuprofen—CXCL8—brain—acquired immunodeficiency syndrome	0.000346	0.00565	CbGeAlD
Ibuprofen—CXCL8—lymph node—acquired immunodeficiency syndrome	0.000334	0.00546	CbGeAlD
Ibuprofen—SLCO2B1—digestive system—acquired immunodeficiency syndrome	0.000311	0.00508	CbGeAlD
Ibuprofen—PPARG—lymphoid tissue—acquired immunodeficiency syndrome	0.000307	0.00502	CbGeAlD
Ibuprofen—PPARG—digestive system—acquired immunodeficiency syndrome	0.000303	0.00496	CbGeAlD
Ibuprofen—PPARG—blood—acquired immunodeficiency syndrome	0.000289	0.00472	CbGeAlD
Ibuprofen—SLCO1A2—digestive system—acquired immunodeficiency syndrome	0.000286	0.00468	CbGeAlD
Ibuprofen—SLCO2B1—spinal cord—acquired immunodeficiency syndrome	0.000286	0.00467	CbGeAlD
Ibuprofen—PPARG—bone marrow—acquired immunodeficiency syndrome	0.00028	0.00457	CbGeAlD
Ibuprofen—ABCC4—digestive system—acquired immunodeficiency syndrome	0.000276	0.0045	CbGeAlD
Ibuprofen—SLC22A6—brain—acquired immunodeficiency syndrome	0.00027	0.00441	CbGeAlD
Ibuprofen—PPARG—vagina—acquired immunodeficiency syndrome	0.000268	0.00438	CbGeAlD
Ibuprofen—SLCO1A2—spinal cord—acquired immunodeficiency syndrome	0.000263	0.00429	CbGeAlD
Ibuprofen—ABCC4—blood—acquired immunodeficiency syndrome	0.000263	0.00429	CbGeAlD
Ibuprofen—SLC22A8—blood—acquired immunodeficiency syndrome	0.00026	0.00426	CbGeAlD
Ibuprofen—SLCO2B1—lung—acquired immunodeficiency syndrome	0.00026	0.00425	CbGeAlD
Ibuprofen—ABCC4—bone marrow—acquired immunodeficiency syndrome	0.000254	0.00415	CbGeAlD
Ibuprofen—PPARG—lung—acquired immunodeficiency syndrome	0.000253	0.00414	CbGeAlD
Ibuprofen—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000249	0.00408	CbGeAlD
Ibuprofen—SLCO2B1—nervous system—acquired immunodeficiency syndrome	0.000241	0.00393	CbGeAlD
Ibuprofen—SLCO1A2—lung—acquired immunodeficiency syndrome	0.000239	0.00391	CbGeAlD
Ibuprofen—PPARG—nervous system—acquired immunodeficiency syndrome	0.000235	0.00383	CbGeAlD
Ibuprofen—SLCO2B1—central nervous system—acquired immunodeficiency syndrome	0.000232	0.00379	CbGeAlD
Ibuprofen—ABCC4—lung—acquired immunodeficiency syndrome	0.00023	0.00376	CbGeAlD
Ibuprofen—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000229	0.00374	CbGeAlD
Ibuprofen—PPARG—central nervous system—acquired immunodeficiency syndrome	0.000226	0.00369	CbGeAlD
Ibuprofen—ABCC1—blood—acquired immunodeficiency syndrome	0.000224	0.00366	CbGeAlD
Ibuprofen—SLCO1A2—nervous system—acquired immunodeficiency syndrome	0.000221	0.00362	CbGeAlD
Ibuprofen—CYP2C19—blood—acquired immunodeficiency syndrome	0.000218	0.00357	CbGeAlD
Ibuprofen—SLCO1A2—central nervous system—acquired immunodeficiency syndrome	0.000213	0.00348	CbGeAlD
Ibuprofen—ABCC4—nervous system—acquired immunodeficiency syndrome	0.000213	0.00348	CbGeAlD
Ibuprofen—SLC22A8—nervous system—acquired immunodeficiency syndrome	0.000211	0.00345	CbGeAlD
Ibuprofen—ABCC1—vagina—acquired immunodeficiency syndrome	0.000207	0.00339	CbGeAlD
Ibuprofen—ABCC4—central nervous system—acquired immunodeficiency syndrome	0.000205	0.00335	CbGeAlD
Ibuprofen—SLC22A8—central nervous system—acquired immunodeficiency syndrome	0.000204	0.00333	CbGeAlD
Ibuprofen—PTGS1—skin of body—acquired immunodeficiency syndrome	0.000203	0.00331	CbGeAlD
Ibuprofen—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000202	0.00331	CbGeAlD
Ibuprofen—ABCC1—lung—acquired immunodeficiency syndrome	0.000196	0.00321	CbGeAlD
Ibuprofen—PTGS2—skin of body—acquired immunodeficiency syndrome	0.000194	0.00317	CbGeAlD
Ibuprofen—CYP2C8—blood—acquired immunodeficiency syndrome	0.000191	0.00311	CbGeAlD
Ibuprofen—SLCO2B1—brain—acquired immunodeficiency syndrome	0.000184	0.003	CbGeAlD
Ibuprofen—PPARG—brain—acquired immunodeficiency syndrome	0.000179	0.00293	CbGeAlD
Ibuprofen—Fenoprofen—ALB—acquired immunodeficiency syndrome	0.000178	0.0541	CrCbGaD
Ibuprofen—SLCO2B1—lymph node—acquired immunodeficiency syndrome	0.000178	0.0029	CbGeAlD
Ibuprofen—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000178	0.0029	CbGeAlD
Ibuprofen—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000177	0.00289	CbGeAlD
Ibuprofen—PPARG—lymph node—acquired immunodeficiency syndrome	0.000173	0.00283	CbGeAlD
Ibuprofen—CYP2C9—blood—acquired immunodeficiency syndrome	0.000169	0.00277	CbGeAlD
Ibuprofen—SLCO1A2—brain—acquired immunodeficiency syndrome	0.000169	0.00277	CbGeAlD
Ibuprofen—ALB—brain—acquired immunodeficiency syndrome	0.000168	0.00275	CbGeAlD
Ibuprofen—ABCC4—brain—acquired immunodeficiency syndrome	0.000163	0.00266	CbGeAlD
Ibuprofen—ALB—lymph node—acquired immunodeficiency syndrome	0.000163	0.00266	CbGeAlD
Ibuprofen—PTGS1—digestive system—acquired immunodeficiency syndrome	0.000162	0.00265	CbGeAlD
Ibuprofen—Naproxen—ALB—acquired immunodeficiency syndrome	0.000162	0.0492	CrCbGaD
Ibuprofen—SLC22A8—brain—acquired immunodeficiency syndrome	0.000162	0.00264	CbGeAlD
Ibuprofen—ABCC4—lymph node—acquired immunodeficiency syndrome	0.000157	0.00257	CbGeAlD
Ibuprofen—PTGS2—lymphoid tissue—acquired immunodeficiency syndrome	0.000157	0.00256	CbGeAlD
Ibuprofen—PTGS2—digestive system—acquired immunodeficiency syndrome	0.000155	0.00253	CbGeAlD
Ibuprofen—PTGS1—blood—acquired immunodeficiency syndrome	0.000155	0.00253	CbGeAlD
Ibuprofen—PTGS1—spinal cord—acquired immunodeficiency syndrome	0.000149	0.00243	CbGeAlD
Ibuprofen—PTGS2—blood—acquired immunodeficiency syndrome	0.000148	0.00241	CbGeAlD
Ibuprofen—PTGS1—vagina—acquired immunodeficiency syndrome	0.000143	0.00234	CbGeAlD
Ibuprofen—PTGS2—bone marrow—acquired immunodeficiency syndrome	0.000143	0.00234	CbGeAlD
Ibuprofen—PTGS2—spinal cord—acquired immunodeficiency syndrome	0.000142	0.00233	CbGeAlD
Ibuprofen—ABCC1—brain—acquired immunodeficiency syndrome	0.000139	0.00227	CbGeAlD
Ibuprofen—PTGS2—vagina—acquired immunodeficiency syndrome	0.000137	0.00224	CbGeAlD
Ibuprofen—ABCB1—retina—acquired immunodeficiency syndrome	0.000137	0.00223	CbGeAlD
Ibuprofen—PTGS1—lung—acquired immunodeficiency syndrome	0.000135	0.00221	CbGeAlD
Ibuprofen—ABCC1—lymph node—acquired immunodeficiency syndrome	0.000134	0.00219	CbGeAlD
Ibuprofen—PTGS2—lung—acquired immunodeficiency syndrome	0.000129	0.00212	CbGeAlD
Ibuprofen—PTGS1—nervous system—acquired immunodeficiency syndrome	0.000125	0.00205	CbGeAlD
Ibuprofen—PTGS1—central nervous system—acquired immunodeficiency syndrome	0.000121	0.00197	CbGeAlD
Ibuprofen—PTGS2—nervous system—acquired immunodeficiency syndrome	0.00012	0.00196	CbGeAlD
Ibuprofen—CYP2C8—brain—acquired immunodeficiency syndrome	0.000118	0.00193	CbGeAlD
Ibuprofen—Flurbiprofen—ALB—acquired immunodeficiency syndrome	0.000116	0.0353	CrCbGaD
Ibuprofen—PTGS2—central nervous system—acquired immunodeficiency syndrome	0.000115	0.00189	CbGeAlD
Ibuprofen—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	9.71e-05	0.00159	CbGeAlD
Ibuprofen—ABCB1—digestive system—acquired immunodeficiency syndrome	9.59e-05	0.00157	CbGeAlD
Ibuprofen—PTGS1—brain—acquired immunodeficiency syndrome	9.59e-05	0.00157	CbGeAlD
Ibuprofen—PTGS1—lymph node—acquired immunodeficiency syndrome	9.27e-05	0.00151	CbGeAlD
Ibuprofen—PTGS2—brain—acquired immunodeficiency syndrome	9.17e-05	0.0015	CbGeAlD
Ibuprofen—ABCB1—blood—acquired immunodeficiency syndrome	9.14e-05	0.00149	CbGeAlD
Ibuprofen—PTGS2—lymph node—acquired immunodeficiency syndrome	8.86e-05	0.00145	CbGeAlD
Ibuprofen—ABCB1—bone marrow—acquired immunodeficiency syndrome	8.84e-05	0.00144	CbGeAlD
Ibuprofen—ABCB1—spinal cord—acquired immunodeficiency syndrome	8.8e-05	0.00144	CbGeAlD
Ibuprofen—ABCB1—vagina—acquired immunodeficiency syndrome	8.47e-05	0.00138	CbGeAlD
Ibuprofen—ABCB1—lung—acquired immunodeficiency syndrome	8.01e-05	0.00131	CbGeAlD
Ibuprofen—ABCB1—nervous system—acquired immunodeficiency syndrome	7.42e-05	0.00121	CbGeAlD
Ibuprofen—CXCL8—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	7.28e-05	0.00193	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	7.28e-05	0.00193	CbGpPWpGaD
Ibuprofen—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—acquired immunodeficiency syndrome	7.18e-05	0.0019	CbGpPWpGaD
Ibuprofen—ABCB1—central nervous system—acquired immunodeficiency syndrome	7.14e-05	0.00117	CbGeAlD
Ibuprofen—CXCL8—Spinal Cord Injury—IFNG—acquired immunodeficiency syndrome	7.08e-05	0.00188	CbGpPWpGaD
Ibuprofen—PLAT—Senescence and Autophagy in Cancer—IL6—acquired immunodeficiency syndrome	7.04e-05	0.00187	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	7.02e-05	0.00186	CbGpPWpGaD
Ibuprofen—PTGS2—Overview of nanoparticle effects—IL6—acquired immunodeficiency syndrome	6.98e-05	0.00185	CbGpPWpGaD
Ibuprofen—CXCL8—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	6.97e-05	0.00185	CbGpPWpGaD
Ibuprofen—ABCB1—Allograft Rejection—CXCL12—acquired immunodeficiency syndrome	6.8e-05	0.0018	CbGpPWpGaD
Ibuprofen—BCL2—ATF-2 transcription factor network—IL6—acquired immunodeficiency syndrome	6.7e-05	0.00178	CbGpPWpGaD
Ibuprofen—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	6.63e-05	0.000391	CcSEcCtD
Ibuprofen—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	6.63e-05	0.000391	CcSEcCtD
Ibuprofen—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	6.62e-05	0.00039	CcSEcCtD
Ibuprofen—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	6.62e-05	0.00039	CcSEcCtD
Ibuprofen—ALB—Folate Metabolism—IL4—acquired immunodeficiency syndrome	6.61e-05	0.00175	CbGpPWpGaD
Ibuprofen—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	6.61e-05	0.00039	CcSEcCtD
Ibuprofen—Pruritus—Stavudine—acquired immunodeficiency syndrome	6.6e-05	0.000389	CcSEcCtD
Ibuprofen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	6.59e-05	0.00175	CbGpPWpGaD
Ibuprofen—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	6.59e-05	0.00175	CbGpPWpGaD
Ibuprofen—Asthenia—Abacavir—acquired immunodeficiency syndrome	6.59e-05	0.000389	CcSEcCtD
Ibuprofen—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	6.59e-05	0.000389	CcSEcCtD
Ibuprofen—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	6.58e-05	0.000388	CcSEcCtD
Ibuprofen—PPARG—Developmental Biology—ACTG1—acquired immunodeficiency syndrome	6.57e-05	0.00174	CbGpPWpGaD
Ibuprofen—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	6.57e-05	0.000388	CcSEcCtD
Ibuprofen—Myalgia—Ritonavir—acquired immunodeficiency syndrome	6.57e-05	0.000388	CcSEcCtD
Ibuprofen—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	6.55e-05	0.000387	CcSEcCtD
Ibuprofen—Anaemia—Lamivudine—acquired immunodeficiency syndrome	6.55e-05	0.000387	CcSEcCtD
Ibuprofen—Anxiety—Ritonavir—acquired immunodeficiency syndrome	6.55e-05	0.000386	CcSEcCtD
Ibuprofen—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	6.53e-05	0.000385	CcSEcCtD
Ibuprofen—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	6.53e-05	0.000385	CcSEcCtD
Ibuprofen—CXCL8—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	6.52e-05	0.00173	CbGpPWpGaD
Ibuprofen—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	6.51e-05	0.000384	CcSEcCtD
Ibuprofen—Pruritus—Abacavir—acquired immunodeficiency syndrome	6.5e-05	0.000383	CcSEcCtD
Ibuprofen—Fatigue—Indinavir—acquired immunodeficiency syndrome	6.5e-05	0.000383	CcSEcCtD
Ibuprofen—Anorexia—Delavirdine—acquired immunodeficiency syndrome	6.49e-05	0.000383	CcSEcCtD
Ibuprofen—Discomfort—Ritonavir—acquired immunodeficiency syndrome	6.49e-05	0.000383	CcSEcCtD
Ibuprofen—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	6.49e-05	0.000383	CcSEcCtD
Ibuprofen—Cough—Saquinavir—acquired immunodeficiency syndrome	6.48e-05	0.000383	CcSEcCtD
Ibuprofen—Angioedema—Lamivudine—acquired immunodeficiency syndrome	6.48e-05	0.000382	CcSEcCtD
Ibuprofen—Constipation—Indinavir—acquired immunodeficiency syndrome	6.44e-05	0.00038	CcSEcCtD
Ibuprofen—PLAT—Hemostasis—CSF2—acquired immunodeficiency syndrome	6.44e-05	0.00171	CbGpPWpGaD
Ibuprofen—CXCL8—ATF-2 transcription factor network—IL6—acquired immunodeficiency syndrome	6.44e-05	0.00171	CbGpPWpGaD
Ibuprofen—Insomnia—Efavirenz—acquired immunodeficiency syndrome	6.44e-05	0.00038	CcSEcCtD
Ibuprofen—Urticaria—Zidovudine—acquired immunodeficiency syndrome	6.44e-05	0.00038	CcSEcCtD
Ibuprofen—Convulsion—Saquinavir—acquired immunodeficiency syndrome	6.44e-05	0.00038	CcSEcCtD
Ibuprofen—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	6.43e-05	0.000379	CcSEcCtD
Ibuprofen—Hypertension—Saquinavir—acquired immunodeficiency syndrome	6.41e-05	0.000378	CcSEcCtD
Ibuprofen—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	6.41e-05	0.000378	CcSEcCtD
Ibuprofen—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	6.4e-05	0.000378	CcSEcCtD
Ibuprofen—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	6.39e-05	0.000377	CcSEcCtD
Ibuprofen—Malaise—Lamivudine—acquired immunodeficiency syndrome	6.39e-05	0.000377	CcSEcCtD
Ibuprofen—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	6.38e-05	0.000376	CcSEcCtD
Ibuprofen—Nausea—Didanosine—acquired immunodeficiency syndrome	6.38e-05	0.000376	CcSEcCtD
Ibuprofen—Vertigo—Lamivudine—acquired immunodeficiency syndrome	6.37e-05	0.000376	CcSEcCtD
Ibuprofen—Hypotension—Delavirdine—acquired immunodeficiency syndrome	6.37e-05	0.000376	CcSEcCtD
Ibuprofen—Syncope—Lamivudine—acquired immunodeficiency syndrome	6.36e-05	0.000375	CcSEcCtD
Ibuprofen—Confusional state—Ritonavir—acquired immunodeficiency syndrome	6.35e-05	0.000375	CcSEcCtD
Ibuprofen—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	6.35e-05	0.000375	CcSEcCtD
Ibuprofen—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	6.34e-05	0.000374	CcSEcCtD
Ibuprofen—Somnolence—Efavirenz—acquired immunodeficiency syndrome	6.33e-05	0.000373	CcSEcCtD
Ibuprofen—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	6.32e-05	0.000373	CcSEcCtD
Ibuprofen—Myalgia—Saquinavir—acquired immunodeficiency syndrome	6.32e-05	0.000373	CcSEcCtD
Ibuprofen—CXCL8—Allograft Rejection—TNF—acquired immunodeficiency syndrome	6.32e-05	0.00168	CbGpPWpGaD
Ibuprofen—Anxiety—Saquinavir—acquired immunodeficiency syndrome	6.3e-05	0.000372	CcSEcCtD
Ibuprofen—BCL2—Innate Immune System—MBL2—acquired immunodeficiency syndrome	6.3e-05	0.00167	CbGpPWpGaD
Ibuprofen—Oedema—Ritonavir—acquired immunodeficiency syndrome	6.3e-05	0.000372	CcSEcCtD
Ibuprofen—CXCL8—Spinal Cord Injury—IL2—acquired immunodeficiency syndrome	6.29e-05	0.00167	CbGpPWpGaD
Ibuprofen—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	6.28e-05	0.000371	CcSEcCtD
Ibuprofen—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	6.28e-05	0.000371	CcSEcCtD
Ibuprofen—CXCL8—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	6.28e-05	0.00167	CbGpPWpGaD
Ibuprofen—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	6.27e-05	0.00037	CcSEcCtD
Ibuprofen—BCL2—Apoptosis—TNF—acquired immunodeficiency syndrome	6.26e-05	0.00166	CbGpPWpGaD
Ibuprofen—Discomfort—Saquinavir—acquired immunodeficiency syndrome	6.25e-05	0.000369	CcSEcCtD
Ibuprofen—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	6.23e-05	0.000368	CcSEcCtD
Ibuprofen—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	6.21e-05	0.000366	CcSEcCtD
Ibuprofen—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	6.21e-05	0.000366	CcSEcCtD
Ibuprofen—Shock—Ritonavir—acquired immunodeficiency syndrome	6.2e-05	0.000366	CcSEcCtD
Ibuprofen—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	6.19e-05	0.000365	CcSEcCtD
Ibuprofen—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	6.19e-05	0.000365	CcSEcCtD
Ibuprofen—Cough—Lamivudine—acquired immunodeficiency syndrome	6.18e-05	0.000365	CcSEcCtD
Ibuprofen—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	6.18e-05	0.000365	CcSEcCtD
Ibuprofen—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	6.18e-05	0.000365	CcSEcCtD
Ibuprofen—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	6.17e-05	0.000364	CcSEcCtD
Ibuprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—acquired immunodeficiency syndrome	6.17e-05	0.00164	CbGpPWpGaD
Ibuprofen—Dizziness—Stavudine—acquired immunodeficiency syndrome	6.16e-05	0.000364	CcSEcCtD
Ibuprofen—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	6.16e-05	0.000364	CcSEcCtD
Ibuprofen—Insomnia—Delavirdine—acquired immunodeficiency syndrome	6.16e-05	0.000364	CcSEcCtD
Ibuprofen—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	6.15e-05	0.000363	CcSEcCtD
Ibuprofen—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	6.15e-05	0.000363	CcSEcCtD
Ibuprofen—Convulsion—Lamivudine—acquired immunodeficiency syndrome	6.14e-05	0.000362	CcSEcCtD
Ibuprofen—Vomiting—Nevirapine—acquired immunodeficiency syndrome	6.14e-05	0.000362	CcSEcCtD
Ibuprofen—Fatigue—Efavirenz—acquired immunodeficiency syndrome	6.14e-05	0.000362	CcSEcCtD
Ibuprofen—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	6.12e-05	0.000361	CcSEcCtD
Ibuprofen—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	6.12e-05	0.000361	CcSEcCtD
Ibuprofen—Confusional state—Saquinavir—acquired immunodeficiency syndrome	6.11e-05	0.000361	CcSEcCtD
Ibuprofen—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	6.09e-05	0.000359	CcSEcCtD
Ibuprofen—Constipation—Efavirenz—acquired immunodeficiency syndrome	6.09e-05	0.000359	CcSEcCtD
Ibuprofen—Rash—Nevirapine—acquired immunodeficiency syndrome	6.09e-05	0.000359	CcSEcCtD
Ibuprofen—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	6.08e-05	0.000359	CcSEcCtD
Ibuprofen—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	6.07e-05	0.000358	CcSEcCtD
Ibuprofen—Dizziness—Abacavir—acquired immunodeficiency syndrome	6.07e-05	0.000358	CcSEcCtD
Ibuprofen—Oedema—Saquinavir—acquired immunodeficiency syndrome	6.06e-05	0.000358	CcSEcCtD
Ibuprofen—Somnolence—Delavirdine—acquired immunodeficiency syndrome	6.06e-05	0.000357	CcSEcCtD
Ibuprofen—Headache—Nevirapine—acquired immunodeficiency syndrome	6.05e-05	0.000357	CcSEcCtD
Ibuprofen—Myalgia—Lamivudine—acquired immunodeficiency syndrome	6.03e-05	0.000356	CcSEcCtD
Ibuprofen—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	6.03e-05	0.000356	CcSEcCtD
Ibuprofen—Infection—Saquinavir—acquired immunodeficiency syndrome	6.02e-05	0.000355	CcSEcCtD
Ibuprofen—Anxiety—Lamivudine—acquired immunodeficiency syndrome	6.01e-05	0.000355	CcSEcCtD
Ibuprofen—Anorexia—Ritonavir—acquired immunodeficiency syndrome	6e-05	0.000354	CcSEcCtD
Ibuprofen—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	6e-05	0.000354	CcSEcCtD
Ibuprofen—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	5.99e-05	0.000354	CcSEcCtD
Ibuprofen—Urticaria—Indinavir—acquired immunodeficiency syndrome	5.99e-05	0.000353	CcSEcCtD
Ibuprofen—Shock—Saquinavir—acquired immunodeficiency syndrome	5.97e-05	0.000352	CcSEcCtD
Ibuprofen—Discomfort—Lamivudine—acquired immunodeficiency syndrome	5.96e-05	0.000352	CcSEcCtD
Ibuprofen—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	5.96e-05	0.000352	CcSEcCtD
Ibuprofen—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	5.95e-05	0.000351	CcSEcCtD
Ibuprofen—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	5.95e-05	0.000351	CcSEcCtD
Ibuprofen—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	5.94e-05	0.00035	CcSEcCtD
Ibuprofen—PTGS1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	5.93e-05	0.00157	CbGpPWpGaD
Ibuprofen—Vomiting—Stavudine—acquired immunodeficiency syndrome	5.93e-05	0.00035	CcSEcCtD
Ibuprofen—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	5.92e-05	0.000349	CcSEcCtD
Ibuprofen—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	5.9e-05	0.000348	CcSEcCtD
Ibuprofen—CXCL8—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	5.9e-05	0.00156	CbGpPWpGaD
Ibuprofen—Rash—Nelfinavir—acquired immunodeficiency syndrome	5.9e-05	0.000348	CcSEcCtD
Ibuprofen—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	5.89e-05	0.000348	CcSEcCtD
Ibuprofen—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	5.89e-05	0.000348	CcSEcCtD
Ibuprofen—Hypotension—Ritonavir—acquired immunodeficiency syndrome	5.89e-05	0.000347	CcSEcCtD
Ibuprofen—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	5.88e-05	0.000347	CcSEcCtD
Ibuprofen—Rash—Stavudine—acquired immunodeficiency syndrome	5.88e-05	0.000347	CcSEcCtD
Ibuprofen—Fatigue—Delavirdine—acquired immunodeficiency syndrome	5.87e-05	0.000347	CcSEcCtD
Ibuprofen—Dermatitis—Stavudine—acquired immunodeficiency syndrome	5.87e-05	0.000347	CcSEcCtD
Ibuprofen—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	5.87e-05	0.000346	CcSEcCtD
Ibuprofen—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	5.86e-05	0.000346	CcSEcCtD
Ibuprofen—Headache—Nelfinavir—acquired immunodeficiency syndrome	5.86e-05	0.000346	CcSEcCtD
Ibuprofen—Headache—Stavudine—acquired immunodeficiency syndrome	5.84e-05	0.000345	CcSEcCtD
Ibuprofen—Vomiting—Abacavir—acquired immunodeficiency syndrome	5.84e-05	0.000345	CcSEcCtD
Ibuprofen—Confusional state—Lamivudine—acquired immunodeficiency syndrome	5.83e-05	0.000344	CcSEcCtD
Ibuprofen—Constipation—Delavirdine—acquired immunodeficiency syndrome	5.83e-05	0.000344	CcSEcCtD
Ibuprofen—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	5.82e-05	0.000344	CcSEcCtD
Ibuprofen—Asthenia—Zidovudine—acquired immunodeficiency syndrome	5.81e-05	0.000343	CcSEcCtD
Ibuprofen—Rash—Abacavir—acquired immunodeficiency syndrome	5.79e-05	0.000342	CcSEcCtD
Ibuprofen—Dermatitis—Abacavir—acquired immunodeficiency syndrome	5.78e-05	0.000341	CcSEcCtD
Ibuprofen—Oedema—Lamivudine—acquired immunodeficiency syndrome	5.78e-05	0.000341	CcSEcCtD
Ibuprofen—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	5.78e-05	0.000341	CcSEcCtD
Ibuprofen—Anorexia—Saquinavir—acquired immunodeficiency syndrome	5.78e-05	0.000341	CcSEcCtD
Ibuprofen—Headache—Abacavir—acquired immunodeficiency syndrome	5.75e-05	0.000339	CcSEcCtD
Ibuprofen—Infection—Lamivudine—acquired immunodeficiency syndrome	5.75e-05	0.000339	CcSEcCtD
Ibuprofen—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	5.74e-05	0.000339	CcSEcCtD
Ibuprofen—Nausea—Nevirapine—acquired immunodeficiency syndrome	5.73e-05	0.000338	CcSEcCtD
Ibuprofen—Pruritus—Zidovudine—acquired immunodeficiency syndrome	5.73e-05	0.000338	CcSEcCtD
Ibuprofen—Insomnia—Ritonavir—acquired immunodeficiency syndrome	5.7e-05	0.000336	CcSEcCtD
Ibuprofen—Shock—Lamivudine—acquired immunodeficiency syndrome	5.69e-05	0.000336	CcSEcCtD
Ibuprofen—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	5.67e-05	0.000335	CcSEcCtD
Ibuprofen—ABCB1—brain—acquired immunodeficiency syndrome	5.67e-05	0.000926	CbGeAlD
Ibuprofen—Hypotension—Saquinavir—acquired immunodeficiency syndrome	5.67e-05	0.000334	CcSEcCtD
Ibuprofen—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	5.66e-05	0.000334	CcSEcCtD
Ibuprofen—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	5.66e-05	0.000334	CcSEcCtD
Ibuprofen—Urticaria—Efavirenz—acquired immunodeficiency syndrome	5.66e-05	0.000334	CcSEcCtD
Ibuprofen—ABCC4—Platelet activation, signaling and aggregation—CSF2—acquired immunodeficiency syndrome	5.65e-05	0.0015	CbGpPWpGaD
Ibuprofen—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	5.63e-05	0.000332	CcSEcCtD
Ibuprofen—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	5.62e-05	0.000332	CcSEcCtD
Ibuprofen—CXCL8—AP-1 transcription factor network—IL6—acquired immunodeficiency syndrome	5.62e-05	0.00149	CbGpPWpGaD
Ibuprofen—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	5.62e-05	0.000331	CcSEcCtD
Ibuprofen—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	5.61e-05	0.000331	CcSEcCtD
Ibuprofen—Somnolence—Ritonavir—acquired immunodeficiency syndrome	5.6e-05	0.00033	CcSEcCtD
Ibuprofen—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	5.59e-05	0.00033	CcSEcCtD
Ibuprofen—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	5.57e-05	0.000329	CcSEcCtD
Ibuprofen—Nausea—Nelfinavir—acquired immunodeficiency syndrome	5.55e-05	0.000328	CcSEcCtD
Ibuprofen—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	5.55e-05	0.000328	CcSEcCtD
Ibuprofen—PLAT—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	5.55e-05	0.00147	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	5.55e-05	0.00147	CbGpPWpGaD
Ibuprofen—CXCL8—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	5.55e-05	0.00147	CbGpPWpGaD
Ibuprofen—CXCL8—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	5.55e-05	0.00147	CbGpPWpGaD
Ibuprofen—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	5.54e-05	0.000327	CcSEcCtD
Ibuprofen—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	5.54e-05	0.000327	CcSEcCtD
Ibuprofen—CXCL8—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	5.54e-05	0.00147	CbGpPWpGaD
Ibuprofen—Nausea—Stavudine—acquired immunodeficiency syndrome	5.54e-05	0.000327	CcSEcCtD
Ibuprofen—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	5.52e-05	0.000326	CcSEcCtD
Ibuprofen—UGT1A3—Metabolism—TAT—acquired immunodeficiency syndrome	5.52e-05	0.00146	CbGpPWpGaD
Ibuprofen—Anorexia—Lamivudine—acquired immunodeficiency syndrome	5.51e-05	0.000325	CcSEcCtD
Ibuprofen—Insomnia—Saquinavir—acquired immunodeficiency syndrome	5.48e-05	0.000324	CcSEcCtD
Ibuprofen—PPARG—Signaling events mediated by HDAC Class I—TNF—acquired immunodeficiency syndrome	5.48e-05	0.00145	CbGpPWpGaD
Ibuprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—acquired immunodeficiency syndrome	5.48e-05	0.00145	CbGpPWpGaD
Ibuprofen—ABCB1—lymph node—acquired immunodeficiency syndrome	5.48e-05	0.000895	CbGeAlD
Ibuprofen—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	5.48e-05	0.000323	CcSEcCtD
Ibuprofen—Nausea—Abacavir—acquired immunodeficiency syndrome	5.45e-05	0.000322	CcSEcCtD
Ibuprofen—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	5.44e-05	0.000321	CcSEcCtD
Ibuprofen—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	5.44e-05	0.000321	CcSEcCtD
Ibuprofen—Fatigue—Ritonavir—acquired immunodeficiency syndrome	5.43e-05	0.00032	CcSEcCtD
Ibuprofen—CXCL8—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	5.42e-05	0.00144	CbGpPWpGaD
Ibuprofen—PTGS1—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	5.42e-05	0.00144	CbGpPWpGaD
Ibuprofen—Urticaria—Delavirdine—acquired immunodeficiency syndrome	5.41e-05	0.000319	CcSEcCtD
Ibuprofen—Asthenia—Indinavir—acquired immunodeficiency syndrome	5.41e-05	0.000319	CcSEcCtD
Ibuprofen—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	5.41e-05	0.000319	CcSEcCtD
Ibuprofen—Hypotension—Lamivudine—acquired immunodeficiency syndrome	5.4e-05	0.000319	CcSEcCtD
Ibuprofen—Somnolence—Saquinavir—acquired immunodeficiency syndrome	5.39e-05	0.000318	CcSEcCtD
Ibuprofen—Constipation—Ritonavir—acquired immunodeficiency syndrome	5.39e-05	0.000318	CcSEcCtD
Ibuprofen—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	5.38e-05	0.000318	CcSEcCtD
Ibuprofen—Dizziness—Zidovudine—acquired immunodeficiency syndrome	5.36e-05	0.000316	CcSEcCtD
Ibuprofen—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	5.34e-05	0.000315	CcSEcCtD
Ibuprofen—Pruritus—Indinavir—acquired immunodeficiency syndrome	5.33e-05	0.000315	CcSEcCtD
Ibuprofen—CXCL8—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	5.28e-05	0.0014	CbGpPWpGaD
Ibuprofen—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	5.27e-05	0.000311	CcSEcCtD
Ibuprofen—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	5.27e-05	0.000311	CcSEcCtD
Ibuprofen—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	5.25e-05	0.00031	CcSEcCtD
Ibuprofen—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	5.23e-05	0.000309	CcSEcCtD
Ibuprofen—Insomnia—Lamivudine—acquired immunodeficiency syndrome	5.23e-05	0.000309	CcSEcCtD
Ibuprofen—Fatigue—Saquinavir—acquired immunodeficiency syndrome	5.23e-05	0.000308	CcSEcCtD
Ibuprofen—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	5.19e-05	0.000306	CcSEcCtD
Ibuprofen—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	5.19e-05	0.000306	CcSEcCtD
Ibuprofen—Constipation—Saquinavir—acquired immunodeficiency syndrome	5.18e-05	0.000306	CcSEcCtD
Ibuprofen—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	5.16e-05	0.000304	CcSEcCtD
Ibuprofen—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	5.16e-05	0.000304	CcSEcCtD
Ibuprofen—ABCB1—Allograft Rejection—IL10—acquired immunodeficiency syndrome	5.16e-05	0.00137	CbGpPWpGaD
Ibuprofen—ABCB1—Allograft Rejection—CD40LG—acquired immunodeficiency syndrome	5.16e-05	0.00137	CbGpPWpGaD
Ibuprofen—Vomiting—Zidovudine—acquired immunodeficiency syndrome	5.15e-05	0.000304	CcSEcCtD
Ibuprofen—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	5.15e-05	0.000304	CcSEcCtD
Ibuprofen—CXCL8—Toll-like Receptor Signaling Pathway—TNF—acquired immunodeficiency syndrome	5.15e-05	0.00137	CbGpPWpGaD
Ibuprofen—Somnolence—Lamivudine—acquired immunodeficiency syndrome	5.14e-05	0.000303	CcSEcCtD
Ibuprofen—PTGS2—Spinal Cord Injury—IL4—acquired immunodeficiency syndrome	5.13e-05	0.00136	CbGpPWpGaD
Ibuprofen—Rash—Zidovudine—acquired immunodeficiency syndrome	5.11e-05	0.000301	CcSEcCtD
Ibuprofen—Asthenia—Efavirenz—acquired immunodeficiency syndrome	5.11e-05	0.000301	CcSEcCtD
Ibuprofen—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	5.1e-05	0.000301	CcSEcCtD
Ibuprofen—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	5.09e-05	0.0003	CcSEcCtD
Ibuprofen—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—acquired immunodeficiency syndrome	5.08e-05	0.00135	CbGpPWpGaD
Ibuprofen—Headache—Zidovudine—acquired immunodeficiency syndrome	5.08e-05	0.0003	CcSEcCtD
Ibuprofen—Pruritus—Efavirenz—acquired immunodeficiency syndrome	5.04e-05	0.000297	CcSEcCtD
Ibuprofen—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	5.03e-05	0.000297	CcSEcCtD
Ibuprofen—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	5.02e-05	0.000296	CcSEcCtD
Ibuprofen—PLAT—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	5.02e-05	0.00133	CbGpPWpGaD
Ibuprofen—ABCB1—Allograft Rejection—IL4—acquired immunodeficiency syndrome	5.02e-05	0.00133	CbGpPWpGaD
Ibuprofen—Urticaria—Ritonavir—acquired immunodeficiency syndrome	5e-05	0.000295	CcSEcCtD
Ibuprofen—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	5e-05	0.000295	CcSEcCtD
Ibuprofen—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	4.99e-05	0.000295	CcSEcCtD
Ibuprofen—CXCL8—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	4.99e-05	0.00132	CbGpPWpGaD
Ibuprofen—Fatigue—Lamivudine—acquired immunodeficiency syndrome	4.99e-05	0.000294	CcSEcCtD
Ibuprofen—Dizziness—Indinavir—acquired immunodeficiency syndrome	4.98e-05	0.000294	CcSEcCtD
Ibuprofen—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	4.98e-05	0.000294	CcSEcCtD
Ibuprofen—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	4.96e-05	0.000293	CcSEcCtD
Ibuprofen—CXCL8—Glucocorticoid receptor regulatory network—IL6—acquired immunodeficiency syndrome	4.95e-05	0.00131	CbGpPWpGaD
Ibuprofen—Constipation—Lamivudine—acquired immunodeficiency syndrome	4.95e-05	0.000292	CcSEcCtD
Ibuprofen—PTGS1—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	4.94e-05	0.00131	CbGpPWpGaD
Ibuprofen—BCL2—Innate Immune System—CCR2—acquired immunodeficiency syndrome	4.94e-05	0.00131	CbGpPWpGaD
Ibuprofen—ALB—Vitamin B12 Metabolism—IFNG—acquired immunodeficiency syndrome	4.91e-05	0.0013	CbGpPWpGaD
Ibuprofen—ABCB1—Allograft Rejection—HLA-B—acquired immunodeficiency syndrome	4.9e-05	0.0013	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	4.9e-05	0.0013	CbGpPWpGaD
Ibuprofen—Asthenia—Delavirdine—acquired immunodeficiency syndrome	4.89e-05	0.000288	CcSEcCtD
Ibuprofen—SLCO2B1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	4.88e-05	0.00129	CbGpPWpGaD
Ibuprofen—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	4.87e-05	0.000287	CcSEcCtD
Ibuprofen—Pruritus—Delavirdine—acquired immunodeficiency syndrome	4.82e-05	0.000284	CcSEcCtD
Ibuprofen—Urticaria—Saquinavir—acquired immunodeficiency syndrome	4.82e-05	0.000284	CcSEcCtD
Ibuprofen—Nausea—Zidovudine—acquired immunodeficiency syndrome	4.81e-05	0.000284	CcSEcCtD
Ibuprofen—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	4.79e-05	0.000283	CcSEcCtD
Ibuprofen—Vomiting—Indinavir—acquired immunodeficiency syndrome	4.79e-05	0.000283	CcSEcCtD
Ibuprofen—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	4.77e-05	0.000281	CcSEcCtD
Ibuprofen—Rash—Indinavir—acquired immunodeficiency syndrome	4.75e-05	0.00028	CcSEcCtD
Ibuprofen—Dermatitis—Indinavir—acquired immunodeficiency syndrome	4.75e-05	0.00028	CcSEcCtD
Ibuprofen—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	4.73e-05	0.000279	CcSEcCtD
Ibuprofen—Headache—Indinavir—acquired immunodeficiency syndrome	4.72e-05	0.000279	CcSEcCtD
Ibuprofen—PTGS2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	4.71e-05	0.00125	CbGpPWpGaD
Ibuprofen—Dizziness—Efavirenz—acquired immunodeficiency syndrome	4.71e-05	0.000278	CcSEcCtD
Ibuprofen—UGT2B7—Metabolism—TAT—acquired immunodeficiency syndrome	4.69e-05	0.00124	CbGpPWpGaD
Ibuprofen—UGT1A3—Metabolism—AGPS—acquired immunodeficiency syndrome	4.69e-05	0.00124	CbGpPWpGaD
Ibuprofen—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	4.66e-05	0.000275	CcSEcCtD
Ibuprofen—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	4.64e-05	0.000274	CcSEcCtD
Ibuprofen—Urticaria—Lamivudine—acquired immunodeficiency syndrome	4.59e-05	0.000271	CcSEcCtD
Ibuprofen—CXCL8—Spinal Cord Injury—TNF—acquired immunodeficiency syndrome	4.58e-05	0.00122	CbGpPWpGaD
Ibuprofen—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	4.57e-05	0.00027	CcSEcCtD
Ibuprofen—PLAT—Signaling by PDGF—IL6—acquired immunodeficiency syndrome	4.53e-05	0.0012	CbGpPWpGaD
Ibuprofen—Vomiting—Efavirenz—acquired immunodeficiency syndrome	4.53e-05	0.000267	CcSEcCtD
Ibuprofen—Asthenia—Ritonavir—acquired immunodeficiency syndrome	4.52e-05	0.000267	CcSEcCtD
Ibuprofen—Dizziness—Delavirdine—acquired immunodeficiency syndrome	4.5e-05	0.000266	CcSEcCtD
Ibuprofen—Rash—Efavirenz—acquired immunodeficiency syndrome	4.49e-05	0.000265	CcSEcCtD
Ibuprofen—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	4.48e-05	0.000265	CcSEcCtD
Ibuprofen—Nausea—Indinavir—acquired immunodeficiency syndrome	4.48e-05	0.000264	CcSEcCtD
Ibuprofen—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	4.47e-05	0.000264	CcSEcCtD
Ibuprofen—BCL2—Immune System—ACTG1—acquired immunodeficiency syndrome	4.47e-05	0.00118	CbGpPWpGaD
Ibuprofen—Headache—Efavirenz—acquired immunodeficiency syndrome	4.46e-05	0.000263	CcSEcCtD
Ibuprofen—Pruritus—Ritonavir—acquired immunodeficiency syndrome	4.46e-05	0.000263	CcSEcCtD
Ibuprofen—BCL2—Innate Immune System—IFNA1—acquired immunodeficiency syndrome	4.45e-05	0.00118	CbGpPWpGaD
Ibuprofen—PPARG—Metabolism—TAT—acquired immunodeficiency syndrome	4.44e-05	0.00118	CbGpPWpGaD
Ibuprofen—SLC22A11—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	4.42e-05	0.00117	CbGpPWpGaD
Ibuprofen—Asthenia—Saquinavir—acquired immunodeficiency syndrome	4.35e-05	0.000257	CcSEcCtD
Ibuprofen—Vomiting—Delavirdine—acquired immunodeficiency syndrome	4.33e-05	0.000256	CcSEcCtD
Ibuprofen—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	4.31e-05	0.000254	CcSEcCtD
Ibuprofen—PTGS2—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	4.3e-05	0.00114	CbGpPWpGaD
Ibuprofen—Rash—Delavirdine—acquired immunodeficiency syndrome	4.3e-05	0.000253	CcSEcCtD
Ibuprofen—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	4.29e-05	0.000253	CcSEcCtD
Ibuprofen—Pruritus—Saquinavir—acquired immunodeficiency syndrome	4.29e-05	0.000253	CcSEcCtD
Ibuprofen—Headache—Delavirdine—acquired immunodeficiency syndrome	4.27e-05	0.000252	CcSEcCtD
Ibuprofen—PTGS2—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	4.27e-05	0.00113	CbGpPWpGaD
Ibuprofen—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	4.26e-05	0.000251	CcSEcCtD
Ibuprofen—Nausea—Efavirenz—acquired immunodeficiency syndrome	4.23e-05	0.00025	CcSEcCtD
Ibuprofen—BCL2—Senescence and Autophagy in Cancer—IL6—acquired immunodeficiency syndrome	4.23e-05	0.00112	CbGpPWpGaD
Ibuprofen—CXCL8—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	4.22e-05	0.00112	CbGpPWpGaD
Ibuprofen—PLAT—Hemostasis—ALB—acquired immunodeficiency syndrome	4.2e-05	0.00111	CbGpPWpGaD
Ibuprofen—Dizziness—Ritonavir—acquired immunodeficiency syndrome	4.17e-05	0.000246	CcSEcCtD
Ibuprofen—CXCL8—Toll-like Receptor Signaling Pathway—IL6—acquired immunodeficiency syndrome	4.16e-05	0.0011	CbGpPWpGaD
Ibuprofen—Asthenia—Lamivudine—acquired immunodeficiency syndrome	4.15e-05	0.000245	CcSEcCtD
Ibuprofen—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	4.15e-05	0.000245	CcSEcCtD
Ibuprofen—Pruritus—Lamivudine—acquired immunodeficiency syndrome	4.09e-05	0.000241	CcSEcCtD
Ibuprofen—SLCO1A2—Metabolism—TAT—acquired immunodeficiency syndrome	4.08e-05	0.00108	CbGpPWpGaD
Ibuprofen—CXCL8—Senescence and Autophagy in Cancer—IL6—acquired immunodeficiency syndrome	4.06e-05	0.00108	CbGpPWpGaD
Ibuprofen—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—IL6—acquired immunodeficiency syndrome	4.06e-05	0.00108	CbGpPWpGaD
Ibuprofen—Nausea—Delavirdine—acquired immunodeficiency syndrome	4.05e-05	0.000239	CcSEcCtD
Ibuprofen—CXCL8—Regulation of toll-like receptor signaling pathway—TNF—acquired immunodeficiency syndrome	4.02e-05	0.00107	CbGpPWpGaD
Ibuprofen—Dizziness—Saquinavir—acquired immunodeficiency syndrome	4.01e-05	0.000237	CcSEcCtD
Ibuprofen—Vomiting—Ritonavir—acquired immunodeficiency syndrome	4.01e-05	0.000236	CcSEcCtD
Ibuprofen—ALB—Folate Metabolism—IFNG—acquired immunodeficiency syndrome	4e-05	0.00106	CbGpPWpGaD
Ibuprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—acquired immunodeficiency syndrome	3.99e-05	0.00106	CbGpPWpGaD
Ibuprofen—UGT2B7—Metabolism—AGPS—acquired immunodeficiency syndrome	3.99e-05	0.00106	CbGpPWpGaD
Ibuprofen—Rash—Ritonavir—acquired immunodeficiency syndrome	3.97e-05	0.000234	CcSEcCtD
Ibuprofen—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	3.97e-05	0.000234	CcSEcCtD
Ibuprofen—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	3.96e-05	0.000234	CcSEcCtD
Ibuprofen—Headache—Ritonavir—acquired immunodeficiency syndrome	3.95e-05	0.000233	CcSEcCtD
Ibuprofen—PTGS2—C-MYB transcription factor network—CD4—acquired immunodeficiency syndrome	3.93e-05	0.00104	CbGpPWpGaD
Ibuprofen—PTGS2—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	3.92e-05	0.00104	CbGpPWpGaD
Ibuprofen—PPARG—Gene Expression—CCNT1—acquired immunodeficiency syndrome	3.88e-05	0.00103	CbGpPWpGaD
Ibuprofen—Vomiting—Saquinavir—acquired immunodeficiency syndrome	3.85e-05	0.000227	CcSEcCtD
Ibuprofen—BCL2—Apoptosis—TNF—acquired immunodeficiency syndrome	3.83e-05	0.00102	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	3.83e-05	0.00102	CbGpPWpGaD
Ibuprofen—Dizziness—Lamivudine—acquired immunodeficiency syndrome	3.82e-05	0.000226	CcSEcCtD
Ibuprofen—Rash—Saquinavir—acquired immunodeficiency syndrome	3.82e-05	0.000226	CcSEcCtD
Ibuprofen—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	3.82e-05	0.000225	CcSEcCtD
Ibuprofen—UGT1A1—Metabolism—TAT—acquired immunodeficiency syndrome	3.81e-05	0.00101	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism—TAT—acquired immunodeficiency syndrome	3.81e-05	0.00101	CbGpPWpGaD
Ibuprofen—ALB—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	3.81e-05	0.00101	CbGpPWpGaD
Ibuprofen—CXCL8—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	3.8e-05	0.00101	CbGpPWpGaD
Ibuprofen—Headache—Saquinavir—acquired immunodeficiency syndrome	3.8e-05	0.000224	CcSEcCtD
Ibuprofen—PPARG—Metabolism—AGPS—acquired immunodeficiency syndrome	3.77e-05	0.001	CbGpPWpGaD
Ibuprofen—Nausea—Ritonavir—acquired immunodeficiency syndrome	3.74e-05	0.000221	CcSEcCtD
Ibuprofen—ABCC4—Hemostasis—IFNA1—acquired immunodeficiency syndrome	3.72e-05	0.000987	CbGpPWpGaD
Ibuprofen—CXCL8—Spinal Cord Injury—IL6—acquired immunodeficiency syndrome	3.7e-05	0.000981	CbGpPWpGaD
Ibuprofen—ABCC4—Platelet activation, signaling and aggregation—ALB—acquired immunodeficiency syndrome	3.68e-05	0.000976	CbGpPWpGaD
Ibuprofen—Vomiting—Lamivudine—acquired immunodeficiency syndrome	3.68e-05	0.000217	CcSEcCtD
Ibuprofen—ABCC1—Metabolism—TAT—acquired immunodeficiency syndrome	3.68e-05	0.000975	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—MBL2—acquired immunodeficiency syndrome	3.67e-05	0.000974	CbGpPWpGaD
Ibuprofen—CXCL8—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	3.67e-05	0.000973	CbGpPWpGaD
Ibuprofen—Rash—Lamivudine—acquired immunodeficiency syndrome	3.65e-05	0.000215	CcSEcCtD
Ibuprofen—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	3.64e-05	0.000215	CcSEcCtD
Ibuprofen—PLAT—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	3.63e-05	0.000964	CbGpPWpGaD
Ibuprofen—Headache—Lamivudine—acquired immunodeficiency syndrome	3.62e-05	0.000214	CcSEcCtD
Ibuprofen—Nausea—Saquinavir—acquired immunodeficiency syndrome	3.6e-05	0.000213	CcSEcCtD
Ibuprofen—ALB—Folate Metabolism—IL2—acquired immunodeficiency syndrome	3.55e-05	0.000942	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—APOBEC3G—acquired immunodeficiency syndrome	3.51e-05	0.000931	CbGpPWpGaD
Ibuprofen—SLCO1A2—Metabolism—AGPS—acquired immunodeficiency syndrome	3.47e-05	0.000921	CbGpPWpGaD
Ibuprofen—Nausea—Lamivudine—acquired immunodeficiency syndrome	3.44e-05	0.000203	CcSEcCtD
Ibuprofen—PLAT—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.43e-05	0.000909	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	3.42e-05	0.000907	CbGpPWpGaD
Ibuprofen—PLAT—Hemostasis—IL2—acquired immunodeficiency syndrome	3.4e-05	0.000903	CbGpPWpGaD
Ibuprofen—SLC22A8—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	3.37e-05	0.000894	CbGpPWpGaD
Ibuprofen—BCL2—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	3.35e-05	0.000888	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	3.35e-05	0.000888	CbGpPWpGaD
Ibuprofen—PPARG—Adipogenesis—TNF—acquired immunodeficiency syndrome	3.34e-05	0.000887	CbGpPWpGaD
Ibuprofen—CXCL8—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	3.33e-05	0.000884	CbGpPWpGaD
Ibuprofen—BCL2—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	3.24e-05	0.000861	CbGpPWpGaD
Ibuprofen—CXCL8—Regulation of toll-like receptor signaling pathway—IL6—acquired immunodeficiency syndrome	3.24e-05	0.000861	CbGpPWpGaD
Ibuprofen—UGT1A1—Metabolism—AGPS—acquired immunodeficiency syndrome	3.24e-05	0.00086	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism—AGPS—acquired immunodeficiency syndrome	3.24e-05	0.00086	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	3.2e-05	0.000849	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	3.2e-05	0.000849	CbGpPWpGaD
Ibuprofen—PTGS1—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	3.2e-05	0.000849	CbGpPWpGaD
Ibuprofen—ALB—Vitamin B12 Metabolism—TNF—acquired immunodeficiency syndrome	3.18e-05	0.000843	CbGpPWpGaD
Ibuprofen—ALB—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	3.17e-05	0.000842	CbGpPWpGaD
Ibuprofen—CXCL8—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	3.13e-05	0.000831	CbGpPWpGaD
Ibuprofen—CXCL8—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	3.13e-05	0.000831	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—AGPS—acquired immunodeficiency syndrome	3.12e-05	0.000829	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	3.12e-05	0.000827	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—TAT—acquired immunodeficiency syndrome	3.11e-05	0.000824	CbGpPWpGaD
Ibuprofen—PTGS2—Spinal Cord Injury—IFNG—acquired immunodeficiency syndrome	3.1e-05	0.000823	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.1e-05	0.000822	CbGpPWpGaD
Ibuprofen—ABCB1—Allograft Rejection—IFNG—acquired immunodeficiency syndrome	3.03e-05	0.000804	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	3.03e-05	0.000803	CbGpPWpGaD
Ibuprofen—SLCO1A2—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	2.99e-05	0.000794	CbGpPWpGaD
Ibuprofen—ABCC4—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	2.98e-05	0.000792	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—CCNT1—acquired immunodeficiency syndrome	2.98e-05	0.000791	CbGpPWpGaD
Ibuprofen—CXCL8—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	2.96e-05	0.000785	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.91e-05	0.000773	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.91e-05	0.000773	CbGpPWpGaD
Ibuprofen—ABCC4—Hemostasis—CSF2—acquired immunodeficiency syndrome	2.91e-05	0.000772	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.89e-05	0.000768	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—CCR2—acquired immunodeficiency syndrome	2.88e-05	0.000764	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.85e-05	0.000755	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.85e-05	0.000755	CbGpPWpGaD
Ibuprofen—SLC22A6—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	2.81e-05	0.000746	CbGpPWpGaD
Ibuprofen—PTGS2—Spinal Cord Injury—IL2—acquired immunodeficiency syndrome	2.76e-05	0.000731	CbGpPWpGaD
Ibuprofen—PPARG—Adipogenesis—IL6—acquired immunodeficiency syndrome	2.7e-05	0.000715	CbGpPWpGaD
Ibuprofen—ABCB1—Allograft Rejection—IL2—acquired immunodeficiency syndrome	2.69e-05	0.000715	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—AGPS—acquired immunodeficiency syndrome	2.64e-05	0.000701	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—IFNA1—acquired immunodeficiency syndrome	2.59e-05	0.000687	CbGpPWpGaD
Ibuprofen—ALB—Folate Metabolism—TNF—acquired immunodeficiency syndrome	2.59e-05	0.000686	CbGpPWpGaD
Ibuprofen—PTGS1—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	2.58e-05	0.000685	CbGpPWpGaD
Ibuprofen—CXCL8—Cellular Senescence—IL6—acquired immunodeficiency syndrome	2.57e-05	0.000682	CbGpPWpGaD
Ibuprofen—ALB—Vitamin B12 Metabolism—IL6—acquired immunodeficiency syndrome	2.56e-05	0.00068	CbGpPWpGaD
Ibuprofen—ALB—Platelet activation, signaling and aggregation—CSF2—acquired immunodeficiency syndrome	2.55e-05	0.000678	CbGpPWpGaD
Ibuprofen—PTGS2—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	2.54e-05	0.000674	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—CD79A—acquired immunodeficiency syndrome	2.52e-05	0.000667	CbGpPWpGaD
Ibuprofen—SLCO2B1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.48e-05	0.000658	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—TAT—acquired immunodeficiency syndrome	2.47e-05	0.000654	CbGpPWpGaD
Ibuprofen—CXCL8—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.38e-05	0.000633	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—APOBEC3G—acquired immunodeficiency syndrome	2.35e-05	0.000625	CbGpPWpGaD
Ibuprofen—CXCL8—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.35e-05	0.000623	CbGpPWpGaD
Ibuprofen—SLC22A11—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.25e-05	0.000596	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.22e-05	0.000588	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.18e-05	0.000579	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.16e-05	0.000574	CbGpPWpGaD
Ibuprofen—CXCL8—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.15e-05	0.00057	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.13e-05	0.000566	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—AGPS—acquired immunodeficiency syndrome	2.1e-05	0.000556	CbGpPWpGaD
Ibuprofen—ALB—Folate Metabolism—IL6—acquired immunodeficiency syndrome	2.09e-05	0.000554	CbGpPWpGaD
Ibuprofen—ALB—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	2.05e-05	0.000545	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—CD40LG—acquired immunodeficiency syndrome	2.05e-05	0.000544	CbGpPWpGaD
Ibuprofen—PTGS2—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	2.05e-05	0.000544	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—CSF2—acquired immunodeficiency syndrome	2.03e-05	0.000538	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—CD8A—acquired immunodeficiency syndrome	2.03e-05	0.000538	CbGpPWpGaD
Ibuprofen—PTGS2—Spinal Cord Injury—TNF—acquired immunodeficiency syndrome	2.01e-05	0.000533	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—TAT—acquired immunodeficiency syndrome	2.01e-05	0.000532	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—CCNT1—acquired immunodeficiency syndrome	2e-05	0.000531	CbGpPWpGaD
Ibuprofen—BCL2—Innate Immune System—CD4—acquired immunodeficiency syndrome	2e-05	0.00053	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2e-05	0.00053	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—TAT—acquired immunodeficiency syndrome	2e-05	0.000529	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.98e-05	0.000525	CbGpPWpGaD
Ibuprofen—ABCB1—Allograft Rejection—TNF—acquired immunodeficiency syndrome	1.96e-05	0.000521	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—HLA-B—acquired immunodeficiency syndrome	1.95e-05	0.000517	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.95e-05	0.000517	CbGpPWpGaD
Ibuprofen—CXCL8—Cellular responses to stress—IL6—acquired immunodeficiency syndrome	1.94e-05	0.000515	CbGpPWpGaD
Ibuprofen—PPARG—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	1.9e-05	0.000505	CbGpPWpGaD
Ibuprofen—ABCC4—Hemostasis—ALB—acquired immunodeficiency syndrome	1.9e-05	0.000503	CbGpPWpGaD
Ibuprofen—UGT2B4—Metabolism—ALB—acquired immunodeficiency syndrome	1.8e-05	0.000476	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—TAT—acquired immunodeficiency syndrome	1.79e-05	0.000475	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.79e-05	0.000474	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—TAT—acquired immunodeficiency syndrome	1.75e-05	0.000464	CbGpPWpGaD
Ibuprofen—PPARG—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.74e-05	0.000461	CbGpPWpGaD
Ibuprofen—SLC22A8—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.71e-05	0.000454	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—AGPS—acquired immunodeficiency syndrome	1.71e-05	0.000453	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—AGPS—acquired immunodeficiency syndrome	1.7e-05	0.00045	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—IFNA1—acquired immunodeficiency syndrome	1.68e-05	0.000446	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.68e-05	0.000446	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.68e-05	0.000446	CbGpPWpGaD
Ibuprofen—ALB—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	1.66e-05	0.00044	CbGpPWpGaD
Ibuprofen—ABCC4—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.64e-05	0.000436	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—TAT—acquired immunodeficiency syndrome	1.63e-05	0.000433	CbGpPWpGaD
Ibuprofen—PTGS2—Spinal Cord Injury—IL6—acquired immunodeficiency syndrome	1.62e-05	0.00043	CbGpPWpGaD
Ibuprofen—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.6e-05	0.000424	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—CXCR4—acquired immunodeficiency syndrome	1.57e-05	0.000416	CbGpPWpGaD
Ibuprofen—ABCC4—Hemostasis—IL2—acquired immunodeficiency syndrome	1.54e-05	0.000408	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—AGPS—acquired immunodeficiency syndrome	1.52e-05	0.000404	CbGpPWpGaD
Ibuprofen—SLCO1A2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.52e-05	0.000403	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.49e-05	0.000396	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—AGPS—acquired immunodeficiency syndrome	1.49e-05	0.000394	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.44e-05	0.000382	CbGpPWpGaD
Ibuprofen—SLC22A6—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.43e-05	0.000379	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—AGPS—acquired immunodeficiency syndrome	1.39e-05	0.000368	CbGpPWpGaD
Ibuprofen—ABCC1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.37e-05	0.000363	CbGpPWpGaD
Ibuprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	1.37e-05	0.000362	CbGpPWpGaD
Ibuprofen—ALB—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	1.35e-05	0.000358	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—CSF2—acquired immunodeficiency syndrome	1.32e-05	0.000349	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.28e-05	0.000339	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.26e-05	0.000334	CbGpPWpGaD
Ibuprofen—CXCL8—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.24e-05	0.000329	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.22e-05	0.000323	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—IFNG—acquired immunodeficiency syndrome	1.21e-05	0.00032	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—CD4—acquired immunodeficiency syndrome	1.16e-05	0.000309	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.15e-05	0.000306	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.15e-05	0.000306	CbGpPWpGaD
Ibuprofen—PPARG—Developmental Biology—TNF—acquired immunodeficiency syndrome	1.15e-05	0.000305	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.13e-05	0.000299	CbGpPWpGaD
Ibuprofen—BCL2—Innate Immune System—IL6—acquired immunodeficiency syndrome	1.08e-05	0.000287	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—CCR5—acquired immunodeficiency syndrome	1.07e-05	0.000285	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—IL2—acquired immunodeficiency syndrome	1.07e-05	0.000284	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—CXCR4—acquired immunodeficiency syndrome	1.05e-05	0.000279	CbGpPWpGaD
Ibuprofen—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	9.68e-06	0.000257	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	9.66e-06	0.000256	CbGpPWpGaD
Ibuprofen—UGT1A3—Metabolism—ALB—acquired immunodeficiency syndrome	9.62e-06	0.000255	CbGpPWpGaD
Ibuprofen—PPARG—Developmental Biology—IL6—acquired immunodeficiency syndrome	9.27e-06	0.000246	CbGpPWpGaD
Ibuprofen—UGT2B7—Metabolism—ALB—acquired immunodeficiency syndrome	8.18e-06	0.000217	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	7.86e-06	0.000208	CbGpPWpGaD
Ibuprofen—PPARG—Metabolism—ALB—acquired immunodeficiency syndrome	7.73e-06	0.000205	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—CCR5—acquired immunodeficiency syndrome	7.21e-06	0.000191	CbGpPWpGaD
Ibuprofen—SLCO1A2—Metabolism—ALB—acquired immunodeficiency syndrome	7.12e-06	0.000189	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	7.01e-06	0.000186	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—IL2—acquired immunodeficiency syndrome	6.96e-06	0.000185	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.78e-06	0.00018	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—CD4—acquired immunodeficiency syndrome	6.74e-06	0.000179	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.66e-06	0.000177	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism—ALB—acquired immunodeficiency syndrome	6.65e-06	0.000176	CbGpPWpGaD
Ibuprofen—UGT1A1—Metabolism—ALB—acquired immunodeficiency syndrome	6.65e-06	0.000176	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.62e-06	0.000176	CbGpPWpGaD
Ibuprofen—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	6.51e-06	0.000173	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—ALB—acquired immunodeficiency syndrome	6.41e-06	0.00017	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	6.4e-06	0.00017	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—IL6—acquired immunodeficiency syndrome	6.3e-06	0.000167	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—ALB—acquired immunodeficiency syndrome	5.42e-06	0.000144	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—CD4—acquired immunodeficiency syndrome	4.53e-06	0.00012	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—ALB—acquired immunodeficiency syndrome	4.3e-06	0.000114	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.91e-06	0.000104	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—IL6—acquired immunodeficiency syndrome	3.65e-06	9.68e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—ALB—acquired immunodeficiency syndrome	3.5e-06	9.28e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—ALB—acquired immunodeficiency syndrome	3.12e-06	8.29e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	3.05e-06	8.09e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—ALB—acquired immunodeficiency syndrome	2.85e-06	7.56e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—IL6—acquired immunodeficiency syndrome	2.45e-06	6.49e-05	CbGpPWpGaD
